Diagnosis and clinical management of chronic graft-versus-host disease

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Chronic graft-versus-host disease (GVHD) affects approximately 60% of allogeneic stem cell transplant recipients surviving beyond 100 days.
• It is a significant cause of morbidity and mortality in these patients.
• While risk factors are known, the underlying pathogenesis of chronic GVHD remains poorly understood.

Purpose of the Study:

• To review the clinical manifestations and diagnostic criteria for chronic GVHD.
• To outline current therapeutic strategies for managing chronic GVHD.
• To highlight the need for further research into the disease's pathogenesis.

Main Methods:

• This is a review article, synthesizing existing literature on chronic GVHD.
• It discusses clinical presentations, diagnostic approaches, and treatment modalities.
• Focuses on management strategies including glucocorticoids, calcineurin inhibitors, and supportive care.

Main Results:

• Current management involves glucocorticoids and calcineurin inhibitors, with emphasis on minimizing steroid side effects.
• Supportive care, including antibiotic prophylaxis, is crucial for managing morbidity and preventing disability.
• Approximately 50% of patients can discontinue immunosuppression within 5 years; 10% require long-term treatment, while 40% face mortality or malignancy.

Conclusions:

• Effective management of chronic GVHD requires a multi-faceted approach including immunosuppression and supportive care.
• Optimizing glucocorticoid use and providing robust supportive care can mitigate complications.
• Further research into the pathogenesis of chronic GVHD is essential for developing more effective therapies.